山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (1): 95-99.doi: 10.6040/j.issn.1673-3770.0.2016.203

• 无栏目 • 上一篇    下一篇

重组人表皮生长因子预防鼻咽癌放射性口腔黏膜炎和急性放射性皮炎的疗效观察

于斌,郑青平,罗展雄,李旌,周媛媛,李中华,王磊黎,贺婵娟,石丰榕   

  1. 广西柳州市人民医院肿瘤放疗科, 广西 柳州 545006
  • 收稿日期:2016-05-09 出版日期:2017-02-16 发布日期:2017-02-16
  • 通讯作者: 郑青平

Efficacy of recombinant human epidermal growth factor in prevention of radioactive oral mucosa inflammation and acute radiation dermatitis for nasopharyngeal carcinoma.

  1. Department of Radiation Oncology, Liuzhou Peoples Hospital, Liuzhou 545006, Guangxi, China
  • Received:2016-05-09 Online:2017-02-16 Published:2017-02-16

HTML

PDF (PC)

3394

摘要： 目的 观察重组人表皮生长因子(rhEGF)预防鼻咽癌(NPC)放射性口腔黏膜炎和急性放射性皮炎的临床疗效。 方法 将2014年1月至2015年12月收治的50例鼻咽癌患者(Ⅱ期5例,Ⅲ期32例,Ⅳa期13例)随机分为试验组(n=26)和对照组(n=24),两组全程均给予调强放射治疗,放疗周期6周,对照组同时采用顺铂单药化疗,每7 d为一周期,化疗周期为5~6周期;试验组在对照组的治疗基础上同期联合重组人表皮生长因子(口腔喷雾和颈部皮肤涂抹凝胶)进行治疗。以完全缓解、部分缓解、疾病稳定和疾病进展评价两组近期疗效,并采用美国国立癌症研究所常规毒性判定标准对不良反应进行评定。 结果 两组近期疗效基本相当(P>0.05);两组未出现因不良反应致死的情况;两组患者在治疗过程中出现的不良反应率基本相当,均以消化道毒性、骨髓抑制、肝功异常为主;两组患者均发生Ⅰ级以上的放射性口腔黏膜炎和颈部急性放射性皮炎,试验组中Ⅱ级以上放射性口腔黏膜炎和急性放射性皮炎的发生率(42.31%和11.54%)均明显低于对照组(70.83%和41.67%),差异均有统计学意义(P=0.042,0.035)。 结论 重组人表皮生长因子同期联合放化疗治疗鼻咽癌可以有效降低放化疗所致的放射性口腔黏膜炎和颈部急性放射性皮炎等不良反应的发生率。

关键词: 重组人表皮生长因子, 放射性口腔黏膜炎, 颈部急性放射性皮炎, 鼻咽癌

Abstract: Objective To observe the efficacy of recombinant human epidermal growth factor(rhEGF)in prevention of radioactive oral mucosa inflammation and acute radiation dermatitis of nasopharyngeal carcinoma(NPC). Methods A total of 50 NPC patients(5 stage Ⅱ, 32 stageⅢ and 13 stage Ⅳa)in the department of radiation oncology of our hospital hospitalized from January 2014 to December 2015 were randomly divided into the experimental group(n=26)and the control group(n=24).The two groups were treated with intensity modulated radiation therapy on the whole course, 6 weeks a radiotherapy cycle. The control group was given cisplatin single agent chemotherapy, and every 7 days for a cycle, 5 to 6 cycles. On the basis of the treatment of the control group, the experimental group was treated with combination of rhEGF(oral spray and neck skin smear gel)in the same period of the treatment. Short-term efficacy of the two groups was evaluated with complete remission, partial remission, stable disease and progression disease. The toxicity and side-effects were evaluated by the National Cancer Institute Common Toxicity Criteria(NCI-CTC). Results The short-term efficacy of the two groups was basically equivalent(P>0.05). No patients died in the two groups due to the toxic side effects, and the main toxicities in the two groups were gastrointestinal toxicity, myelosuppression and abnormal liver function. All patients had happened radioactive oral mucosa inflammation and acute radiation dermatitis of the neck which level was over grade Ⅰ. The incidence of radioactive oral mucosa inflammation and acute radiation dermatitis of the neck over grade Ⅱ level in the experimental group(42.31% and 11.54%)were significantly lower than those of the control group(70.83% and 41.67%)(P=0.042, 0.035). Conclusion The method of combination radiotherapy and chemotherapy with rhEGF in the treatment of NPC can effectively reduce the incidence of 山东大学耳鼻喉眼学报31卷1期 -于斌,等.重组人表皮生长因子预防鼻咽癌放射性口腔黏膜炎和急性放射性皮炎的疗效观察 \=-toxicity and side-effects of radioactive oral mucosa inflammation and acute radiation dermatitis of neck which caused by radiotherapy and chemotherapy.

Key words: Recombinanthuman epidermal growth factor, Radioactive oral mucosa inflammation, Nasopharyngeal carcinoma, Acute radiation dermatitis of the neck

中图分类号: 

  • R739.63
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
[2] 司勇锋,陶仲强.鼻咽癌病因学和防治研究[J].中国耳鼻咽喉头颈外科,2010,17(3):163-165.
[3] Cao SM, Liu ZW, Jia WH, et al. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up[J]. PLoS One, 2011, 6(4):e19100.
[4] Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China[J]. Chin J Cancer, 2011, 30(2):114-119.
[5] 黄启洪,李艳华.四会市1978-2007年鼻咽癌发病趋势分析[J].中国肿瘤,2011,20(8):571-572. HUANG Qihong, LI Yanhua. An Analysis of Trend for Nasopharyngeal Carcinoma Incidence from 1978 to 2007 in Sihui City, Guangdong Province[J]. Chin Cancer, 2011, 20(8):571-572.
[6] 黄祥,曲超,姜新,等.鼻咽癌的治疗进展[J].中国老年学杂志,2015,35(11):3159-3161.
[7] Guigay J. Advances in nasopharyngeal carcinoma[J]. Curr Opin Oncol, 2008, 20(3):264-269.
[8] 钟海林, 陈国谋, 林丹平,等.69例鼻咽癌常规放疗与调强放疗的不良反应比较[J].临床耳鼻咽喉头颈外科杂志,2013,27(9):462-464. ZHONG Hailin, CHEN Guomou, LIN Danping, et al. Comparison of side effects of intensity modulated radiotherapy and conventional radiotherapy in 69cases with nasopharyngeal carcinoma[J]. Clin Otolaryngol Head Neck Surgery, 2013, 27(9):462-464.
[9] 蒋靖, 夏立君.他克莫司软膏联合重组人表皮生长因子凝胶治疗面部激素依赖性皮炎39例[J].中国皮肤性病学杂志, 2012, 26(6):506-508. JIANG Jing, XIA Lijun. Thirty-nine cases of hormone-dependent facial dermatitis treated with tacrolimus ointment and recombinant human epidermal growth factor gel[J]. Chin J Dermatovenereol, 2012, 26(6):506-508.
[10] 中国鼻咽癌临床分期工作委员会.鼻咽癌'92分期修订工作报告[J].中华放射肿瘤学杂志,2009,18(1):2-5.
[11] Schwartz LH, Bogaerts J, Ford R, et al. Evaluation of lymph nodes with RECIST 1.1.[J]. Eur J Cancer, 2009, 45(2):261-267.
[12] 傅志超,程惠华,李东石,等.鼻咽癌强调放疗联合尼妥珠单抗加同期顺铂化疗的临床观察[J].中国肿瘤防治杂志, 2011,18(18):1475-1477.
[13] 张典刚, 黄莉, 耿晓涛, 等. 局部晚期鼻咽癌强调放疗远期疗效分析[J]. 新疆医科大学学报, 2015, 38(1):17-20, 25. ZHANG Diangang, HUANG Li, GENG Xiaotao, et al. Long-term results in locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy[J]. J Xinjiang Med Univ, 2015, 38(1):17-20, 25.
[14] ICRU report 50: Prescribing, recording, and reporting photon beam therapy[S]. Bethesda, MD: International Commission on Radiation Units and Measurem ents, 1993.
[15] ICRU report 62: Prescribing, recording, and reporting photon beam therapy(supplement to ICRU Report 50)[S]. Bethesda, MD: International Commission on Radiation Units and Measurem ents, 1999.
[16] 王跃建,邓燕明,虞幼军,等.鼻咽癌诊断和治疗[M].北京:人民卫生出版社, 2013:440.
[17] Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group(RTOG)and the European Organization for Research and Treatment of Cancer(EORTC)[J]. Int J Radiat Oncol Biol Phys, 1995, 31(5):1341-1346.
[18] 杜立法,王俊杰.放疗杀伤肿瘤细胞机制的研究进展[J].癌症进展,2014,12(4):341-345.
[19] 戴如立,林广明,骆映峰,等.重组人表皮细胞生长因子治疗急性放射性皮肤溃疡的临床观察[J].中国现代药物应用,2010,4(16):59-60.
[20] 刘尚贤,张春. 重组人表皮细胞生长因子在鼻咽癌放疗中预防放射性口咽炎疗效观察[J].中国医药科学,2014,4(20):168-169,172.
[21] 龚倩,谌赟,符一岚,等. 重组人表皮细胞生长因子联合氨磷汀治疗鼻咽癌患者放射性口腔黏膜炎的临床观察[J].中国药房,2015,26(14):1971-1973.
[22] Miyazaki M, Mars WM, Runge D, et al. Phenobarbital suppresses growth and accelerates restoration of differentiation markers of primary culture rat hepatocytes in the chemically defined hepatocyte growth medium containing hepatocyte growth factor and epidermal growth factor[J]. Exp Cell Resh, 1998, 241(2):445-457.
[23] Hong JP, Lee SW, Song SY, et al. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies[J]. Eur J Cancer Care(Engl), 2009, 18(6):636-641.
[24] Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor(EGF)to enhance healing for diabetic foot ulcers[J]. Ann Plast Surg, 2006, 56(4):394-398; discussion 399-400.
[25] 吴宏,李燕,陈洁.重组人表皮生长因子凝胶与硝酸银软膏联合治疗放射性皮肤损伤[J].现代中西医结合杂志,2011,21(15):1678-1679.
[26] 郭杏,谭美云,郭力,等.重组人表皮细胞生长因子对供皮区创面的修复[J].中国组织工程研究,2010,14(5):862-865.
[1] 张彩霞,刘阳云,江文,刘庚勋,曹杭,陈琼,张纪帅. 一氧化氮对鼻咽癌CNE-2细胞株化疗增敏效应的研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 72-78.
[2] 周毅波,龚小蓉,于锋. MiR-150调控Nanog对鼻咽癌侧群细胞增殖、侵袭的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 79-84.
[3] 陈婷婷,郭其云,刘佳琪,刘丽庭. 探讨同期放化疗对儿童青少年鼻咽癌患者生活质量的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 55-58.
[4] 王雅宁,耿博,李百彦,崔朝阳,王启荣. 鼻咽癌放疗后颅底骨感染坏死的治疗体会[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 42-45.
[5] 王君影,李晓峰. 小牛血去蛋白提取物眼用凝胶对鼻咽癌放射治疗后眼角膜内皮细胞损伤的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 76-79.
[6] 赵燕恋, 卢永田, 杨继红, 张娟, 苗芳芳, 李洁萍. 鼻咽癌EGFL7的表达与肿瘤侵袭转移的关系[J]. 山东大学耳鼻喉眼学报, 2015, 29(6): 31-35.
[7] 车娟, 赵洪春, 李金玲, 王延飞. D-二聚体与鼻咽癌预后的关系[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 47-49.
[8] 周慧, 黄雪琴, 胡俊丽, 姚俊, 张月飞, 江枫. 黄芩苷对鼻咽癌化疗期间激素使用影响的实验研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 30-32.
[9] 张中华1，王学海2，蔡晓岚3. 鼻咽癌中p-PTEN、p-Akt、p-FoxO1的表达及意义[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 55-57.
[10] 杨建明. 鼻咽癌放疗前后腭帆张肌横截面积的改变与放射性中耳炎的相关性[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 31-33.
[11] 徐媛媛，曾泉，洪苏玲，胡国华. 新辅助化疗联合同期放化疗与同期放化疗单独治疗鼻咽癌疗效及安全性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(5): 8-14.
[12] 苗北平1，张蕊石2，郭志红3，孙焕吉1，孟庆国1，王晓彬1. 鼻咽癌中VEGF的表达与树突状细胞含量的相关分析及临床意义[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 62-65.
[13] 胡可锦1, 唐瑶云2, 赵素萍2. 多次5ALA介导光动力下存活鼻咽癌细胞的生物学行为分析[J]. 山东大学耳鼻喉眼学报, 2012, 26(3): 33-36.
[14] 钱小飞，陈建良. 鼻咽癌临床特征及82例误诊分析[J]. 山东大学耳鼻喉眼学报, 2010, 24(4): 48-51.
[15] 敬前程1，罗志强1,贺修胜2,周艳丹3. COX-2蛋白在鼻咽癌中的表达及其临床意义[J]. 山东大学耳鼻喉眼学报, 2009, 23(6): 18-.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 赵利敏，倪坤，吴佳丽，陈淑梅，李晓艳. 婴幼儿吸气性喉喘鸣病因分析与治疗[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 49 -51 .
[2] 史春生1，张庆泉2,王强2,孙岩2,葛长艺1. 软腭缺损修复组织瓣的特点[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 86 -88 .
[3] 张令1,孙传义1,许安廷2. 以耳聋就诊的岩尖胆脂瘤1例[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 93 -94 .
[4] 吴彦桥，邸斌，李军，高晓红 . 鼻内镜下难治性鼻出血出血点寻找及止血策略[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 1 -3 .
[5] 罗惠秀，范春涛，邓延华. 阻塞性睡眠呼吸暂停低通气综合征患儿扁桃体腺样体切除术临床疗效分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 17 -20 .
[6] 郝颖娟1，杨庆松2，周跃华2，易省平1，翟长斌2. 飞秒激光在薄瓣LASIK手术中制作的角膜瓣厚度形态观察[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 26 -31 .
[7] 闻华明1，李海祥2. 应用三角函数法估算LASIK术后人工晶状体度数[J]. 山东大学耳鼻喉眼学报, 2013, 27(5): 74 -76 .
[8] 朱见，贺青卿，郑鲁明，范子义，赵国伟，侯蕾，史后彬 . cN0甲状腺微小乳头状癌淋巴结转移高危因素及行预防性清扫临床分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(6): 9 -12 .
[9] 李少华，孙一帆，卢标清. 双软组织血管瓣填塞乳突术腔的临床研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 6 -7 .
[10] 魏希建1，阴瑞兰2，郭星3. 增殖诱导配体在喉鳞状细胞癌中的表达[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 14 -16 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发